Redwood Investment Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Redwood Investment Management's BMY Position: Q2 2026 in Review
Redwood Investment Management increased its Bristol-Myers Squibb (BMY) stake by 13% in Q2 2026, buying an estimated $109K and bringing the position to 15,992 shares worth $921K. The position accounts for 0.09% of the portfolio, ranked #203.
Redwood Investment Management first reported a position in BMY in Q2 2019 and has held it in 19 quarters since. The position peaked at $7.82M in Q1 2024. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Redwood Investment Management held 15,992 shares of Bristol-Myers Squibb worth $921K as of Q2 2026.
- Redwood Investment Management bought 1,894 Bristol-Myers Squibb shares in Q2 2026, an estimated $109K.
- Bristol-Myers Squibb made up 0.09% of Redwood Investment Management's portfolio in Q2 2026, its #203 holding.
- Redwood Investment Management first reported a position in Bristol-Myers Squibb in Q2 2019 and has held it in 19 quarters since.
- Redwood Investment Management's Bristol-Myers Squibb position peaked at $7.82M in Q1 2024.
- 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Redwood Investment Management's 13F filing for Q2 2026, filed 17 Aug 2026.